skip to Main Content

What is Semaglutide?

Semaglutide is an FDA-approved prescription for weight management that can help control your cravings, blood sugar regulation, and appetite to achieve weight loss!

  • Semaglutide is a weight loss medication  received by once weekly injection
  • Semaglutide  is  FDA-approved  for weight loss

How Does Semaglutide Work?

  • Slows down stomach emptying so that after eating, you feel full longer 1
  • Suppresses appetite and food cravings (on average, patients eat ~30% less) 1
  • Lowers blood glucose levels (without making glucose levels too low) 1

Your body naturally produces several substances that affect your appetite. One of these is called glucagon-like peptide-1 (GLP-1). The body produces GLP-1 naturally when you eat. GLP-1 stops you from feeling hungry and makes you feel full or satisfied.

Semaglutide imitates GLP-1 in the body. This means that Semaglutide provides the same effect as this natural substance (GLP-1) in our bodies.

Reduced food intake: Because Semaglutide reduces feelings of hunger, you eat less.

Effect on plaques in your blood vessels: In animal studies, Semaglutide stopped the progression of plaque formation in blood vessels. This is likely why Semaglutide has also been shown to reduce the risk of cardiovascular events and strokes. 2

Who Can Take Semaglutide?

Adult and teenage patients who are looking to lose weight! Semaglutide is FDA-approved for adults and teenagers with a BMI of 27 or above.

Our physicians and nurse practitioners will evaluate you and determine if Semaglutide can help you lose weight and live a healthier life!

Semaglutide can be highly effective in helping obese and overweight patients lose weight. It is safe for individuals with hypertension, type-2 diabetes, and dyslipidemia.

Who Cannot Take Semaglutide?

You CAN NOT take Semaglutide if you have any of the following conditions:

  • personal or family history of Medullary Thyroid Carcinoma (MTC)
  • personal or family history of Multiple Endocrine Neoplasia, type 2 (MEN 2)
  • prior allergic reaction to Semaglutide or any of its ingredients*
  • diabetic retinopathy (diabetic eye disease)
  • pregnant or trying to get pregnant
  • breast-feeding (Semaglutide is present in breast milk)
  • depression with a history of suicidal thoughts
  • history of pancreatitis
  • kidney disease/kidney insufficiency
  • stomach problems
  • diabetes - you must obtain approval for use from an endocrinology or primary care physician)

What Are the Ingredients in Chill Cryotherapy Semaglutide?

The FDA recently issued a warning about compounded Semaglutide that is made with Semaglutide SALT. We want to assure our current and future patients that our compounded Semagltuide is made with Glycogon-Like Peptide-1 -- the same active ingredient found in the brand name drugs Ozempic and Wegovy. We use an FDA-registered and New York state-certified compounding pharmacy that is compliant with all FDA recommendations and regulations. Our pharmacy DOES NOT USE SEMAGLUTIDE SALT!

Please see this graphic which compares the active & inactive ingredients in our Semaglutide compound with the active & inactive ingredients in the brand-name drugs. Our Semaglutide compound includes vitamin B12 to reduce the incidence of nausea, fatigue, and stomach upset.

final ozempic comparison with our semaglutide

Frequently Asked Questions

Pricing

We offer THE LOWEST pricing for Semaglutide weight loss medication!

Click Here to Find Current Pricing and Promotions for Semaglutide @Chill!

We can ship semaglutide directly to YOU! Items purchased from ChillRx Cryotherapy are the sole responsibility of the purchaser once they leave our location. We photo-document ALL injections that leave our premises, including those that are shipped. There are NO REFUNDS for vitamin or medical injections after they leave our location.

Sources

  1. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898914/
  2. The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314963/
  3. Once-Weekly Semaglutide in Adults with Overweight or Obesity https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  4. Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome https://clinicaltrials.gov/ct2/show/NCT05702905
  5. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease https://pubmed.ncbi.nlm.nih.gov/30741689/
  6. Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6 https://www.frontiersin.org/articles/10.3389/fendo.2021.645566/full

Research Articles and Clinical Trials

Back To Top
ChillCryotherapy-RX-logo-300